Cronos Group Inc vs YieldMax NVDA Option Income Strategy ETF — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.11B), while YieldMax NVDA Option Income Strategy ETF trades at $12.83. The key difference: Cronos Group Inc is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| CRON | NVDY | |
|---|---|---|
Market Cap | $1.11B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $3.27 | $17.96 |
52-Week Low | $2.30 | $11.58 |
Enterprise Value | $310.67M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDY trades at $13.00, up 1.72% with a bullish technical signal from moving averages. The ETF generates weekly dividend distributions ranging from $0.09 to $0.15, providing consistent income. Recent news highlights the fund's strategy of selling NVIDIA call options to fund distributions while potentially capping upside. Technical indicators show mixed signals with RSI at extreme levels suggesting potential overbought conditions.
The outlook balances income generation against opportunity cost. While weekly distributions offer attractive yield, the strategy may limit participation in NVIDIA's full growth potential. Key risks include the fund's dependence on NVIDIA's volatility and the trade-off between income and capital appreciation. Investors seeking regular income may find value, but those prioritizing growth might prefer direct NVIDIA exposure.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →